Circulating microparticle proteins obtained in the late first trimester predict spontaneous preterm birth at less than 35 weeks’ gestation: a panel validation with specific characterization by parity

Thomas F. McElrath, David E. Cantonwine, Arun Jeyabalan, Robert C. Doss, Gail Page, James M. Roberts, Brian Brohman, Zhen Zhang, Kevin P. Rosenblatt

Research output: Contribution to journalArticle

Abstract

Background: We have previously shown that protein biomarkers associated with circulating microparticles proteins (CMPs)obtained at the end of the first trimester may detect physiologic changes in maternal–fetal interaction such that the risk of spontaneous preterm delivery ≤35 weeks can be stratified. Objectives: We present here a study extension and validation of the CMP protein multiplex concept using a larger sample set from a multicenter population that allows for model derivation in a training set and characterization in a separate testing set. Materials and Methods: Ethylenediaminetetraacetic acid (EDTA)plasma was obtained from 3 established biobanks (Seattle, Boston, and Pittsburgh). Samples were from patients at a median of 10–12 weeks’ gestation, and the CMPs were isolated via size-exclusion chromatography followed by protein identification via targeted protein analysis using liquid chromatography–multiple reaction monitoring-mass (LC-MRM)spectrometry. A total of 87 women delivered at ≤35 weeks, and 174 women who delivered at term were matched by maternal age (±2 years)and gestational age at sample draw (±2 weeks). From our prior work, the CMP protein multiplex comprising F13A, FBLN1, IC1, ITIH2, and LCAT was selected for validation. Results: For delivery at ≤35 weeks, the receiver operating characteristic (ROC)curve for a panel of CMP proteins (F13A, FBLN1, IC1, ITIH2, and LCAT)revealed an associated area under the ROC curve (AUC)of 0.74 (95% CI, 0.63–0.81). A separate panel of markers (IC1, LCAT, TRFE, and ITIH4), which stratified risk among mothers with a parity of 0, showed an AUC of 0.77 (95% CI, 0.61–0.90). Conclusion: We have identified a set of CMP proteins that provide, at 10–12 weeks gestation, a clinically useful AUC in an independent test population. Furthermore, we determined that parity is pertinent to the diagnostic testing performance of the biomarkers for risk stratification.

Original languageEnglish (US)
Pages (from-to)488.e1-488.e11
JournalAmerican journal of obstetrics and gynecology
Volume220
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Premature Birth
First Pregnancy Trimester
Parity
Pregnancy
Proteins
ROC Curve
Area Under Curve
Biomarkers
Validation Studies
Maternal Age
Edetic Acid
Population
Gestational Age
Gel Chromatography
Mass Spectrometry
Mothers

Keywords

  • exosome
  • microparticle
  • parity
  • proteomics
  • spontaneous preterm birth

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Circulating microparticle proteins obtained in the late first trimester predict spontaneous preterm birth at less than 35 weeks’ gestation : a panel validation with specific characterization by parity. / McElrath, Thomas F.; Cantonwine, David E.; Jeyabalan, Arun; Doss, Robert C.; Page, Gail; Roberts, James M.; Brohman, Brian; Zhang, Zhen; Rosenblatt, Kevin P.

In: American journal of obstetrics and gynecology, Vol. 220, No. 5, 01.05.2019, p. 488.e1-488.e11.

Research output: Contribution to journalArticle

McElrath, Thomas F. ; Cantonwine, David E. ; Jeyabalan, Arun ; Doss, Robert C. ; Page, Gail ; Roberts, James M. ; Brohman, Brian ; Zhang, Zhen ; Rosenblatt, Kevin P. / Circulating microparticle proteins obtained in the late first trimester predict spontaneous preterm birth at less than 35 weeks’ gestation : a panel validation with specific characterization by parity. In: American journal of obstetrics and gynecology. 2019 ; Vol. 220, No. 5. pp. 488.e1-488.e11.
@article{b0bbb649266241dda1a471d7e889aa1c,
title = "Circulating microparticle proteins obtained in the late first trimester predict spontaneous preterm birth at less than 35 weeks’ gestation: a panel validation with specific characterization by parity",
abstract = "Background: We have previously shown that protein biomarkers associated with circulating microparticles proteins (CMPs)obtained at the end of the first trimester may detect physiologic changes in maternal–fetal interaction such that the risk of spontaneous preterm delivery ≤35 weeks can be stratified. Objectives: We present here a study extension and validation of the CMP protein multiplex concept using a larger sample set from a multicenter population that allows for model derivation in a training set and characterization in a separate testing set. Materials and Methods: Ethylenediaminetetraacetic acid (EDTA)plasma was obtained from 3 established biobanks (Seattle, Boston, and Pittsburgh). Samples were from patients at a median of 10–12 weeks’ gestation, and the CMPs were isolated via size-exclusion chromatography followed by protein identification via targeted protein analysis using liquid chromatography–multiple reaction monitoring-mass (LC-MRM)spectrometry. A total of 87 women delivered at ≤35 weeks, and 174 women who delivered at term were matched by maternal age (±2 years)and gestational age at sample draw (±2 weeks). From our prior work, the CMP protein multiplex comprising F13A, FBLN1, IC1, ITIH2, and LCAT was selected for validation. Results: For delivery at ≤35 weeks, the receiver operating characteristic (ROC)curve for a panel of CMP proteins (F13A, FBLN1, IC1, ITIH2, and LCAT)revealed an associated area under the ROC curve (AUC)of 0.74 (95{\%} CI, 0.63–0.81). A separate panel of markers (IC1, LCAT, TRFE, and ITIH4), which stratified risk among mothers with a parity of 0, showed an AUC of 0.77 (95{\%} CI, 0.61–0.90). Conclusion: We have identified a set of CMP proteins that provide, at 10–12 weeks gestation, a clinically useful AUC in an independent test population. Furthermore, we determined that parity is pertinent to the diagnostic testing performance of the biomarkers for risk stratification.",
keywords = "exosome, microparticle, parity, proteomics, spontaneous preterm birth",
author = "McElrath, {Thomas F.} and Cantonwine, {David E.} and Arun Jeyabalan and Doss, {Robert C.} and Gail Page and Roberts, {James M.} and Brian Brohman and Zhen Zhang and Rosenblatt, {Kevin P.}",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.ajog.2019.01.220",
language = "English (US)",
volume = "220",
pages = "488.e1--488.e11",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Circulating microparticle proteins obtained in the late first trimester predict spontaneous preterm birth at less than 35 weeks’ gestation

T2 - a panel validation with specific characterization by parity

AU - McElrath, Thomas F.

AU - Cantonwine, David E.

AU - Jeyabalan, Arun

AU - Doss, Robert C.

AU - Page, Gail

AU - Roberts, James M.

AU - Brohman, Brian

AU - Zhang, Zhen

AU - Rosenblatt, Kevin P.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Background: We have previously shown that protein biomarkers associated with circulating microparticles proteins (CMPs)obtained at the end of the first trimester may detect physiologic changes in maternal–fetal interaction such that the risk of spontaneous preterm delivery ≤35 weeks can be stratified. Objectives: We present here a study extension and validation of the CMP protein multiplex concept using a larger sample set from a multicenter population that allows for model derivation in a training set and characterization in a separate testing set. Materials and Methods: Ethylenediaminetetraacetic acid (EDTA)plasma was obtained from 3 established biobanks (Seattle, Boston, and Pittsburgh). Samples were from patients at a median of 10–12 weeks’ gestation, and the CMPs were isolated via size-exclusion chromatography followed by protein identification via targeted protein analysis using liquid chromatography–multiple reaction monitoring-mass (LC-MRM)spectrometry. A total of 87 women delivered at ≤35 weeks, and 174 women who delivered at term were matched by maternal age (±2 years)and gestational age at sample draw (±2 weeks). From our prior work, the CMP protein multiplex comprising F13A, FBLN1, IC1, ITIH2, and LCAT was selected for validation. Results: For delivery at ≤35 weeks, the receiver operating characteristic (ROC)curve for a panel of CMP proteins (F13A, FBLN1, IC1, ITIH2, and LCAT)revealed an associated area under the ROC curve (AUC)of 0.74 (95% CI, 0.63–0.81). A separate panel of markers (IC1, LCAT, TRFE, and ITIH4), which stratified risk among mothers with a parity of 0, showed an AUC of 0.77 (95% CI, 0.61–0.90). Conclusion: We have identified a set of CMP proteins that provide, at 10–12 weeks gestation, a clinically useful AUC in an independent test population. Furthermore, we determined that parity is pertinent to the diagnostic testing performance of the biomarkers for risk stratification.

AB - Background: We have previously shown that protein biomarkers associated with circulating microparticles proteins (CMPs)obtained at the end of the first trimester may detect physiologic changes in maternal–fetal interaction such that the risk of spontaneous preterm delivery ≤35 weeks can be stratified. Objectives: We present here a study extension and validation of the CMP protein multiplex concept using a larger sample set from a multicenter population that allows for model derivation in a training set and characterization in a separate testing set. Materials and Methods: Ethylenediaminetetraacetic acid (EDTA)plasma was obtained from 3 established biobanks (Seattle, Boston, and Pittsburgh). Samples were from patients at a median of 10–12 weeks’ gestation, and the CMPs were isolated via size-exclusion chromatography followed by protein identification via targeted protein analysis using liquid chromatography–multiple reaction monitoring-mass (LC-MRM)spectrometry. A total of 87 women delivered at ≤35 weeks, and 174 women who delivered at term were matched by maternal age (±2 years)and gestational age at sample draw (±2 weeks). From our prior work, the CMP protein multiplex comprising F13A, FBLN1, IC1, ITIH2, and LCAT was selected for validation. Results: For delivery at ≤35 weeks, the receiver operating characteristic (ROC)curve for a panel of CMP proteins (F13A, FBLN1, IC1, ITIH2, and LCAT)revealed an associated area under the ROC curve (AUC)of 0.74 (95% CI, 0.63–0.81). A separate panel of markers (IC1, LCAT, TRFE, and ITIH4), which stratified risk among mothers with a parity of 0, showed an AUC of 0.77 (95% CI, 0.61–0.90). Conclusion: We have identified a set of CMP proteins that provide, at 10–12 weeks gestation, a clinically useful AUC in an independent test population. Furthermore, we determined that parity is pertinent to the diagnostic testing performance of the biomarkers for risk stratification.

KW - exosome

KW - microparticle

KW - parity

KW - proteomics

KW - spontaneous preterm birth

UR - http://www.scopus.com/inward/record.url?scp=85062037678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062037678&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2019.01.220

DO - 10.1016/j.ajog.2019.01.220

M3 - Article

C2 - 30690014

AN - SCOPUS:85062037678

VL - 220

SP - 488.e1-488.e11

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 5

ER -